Is it time to Buy before this week’s earning report Aurora Cannabis (NYSE:ACB)

0
144

Earnings results for Aurora Cannabis (NYSE:ACB)

Aurora Cannabis Inc. is expected* to report earnings on 09/22/2020 after market close. The report will be for the fiscal Quarter ending Jun 2020. According to Zacks Investment Research, based on 5 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.29. The reported EPS for the same quarter last year was $0.

Analyst Opinion on Aurora Cannabis (NYSE:ACB)

17 Wall Street analysts have issued ratings and price targets for Aurora Cannabis in the last 12 months. Their average twelve-month price target is $17.13, predicting that the stock has a possible upside of 171.10%. The high price target for ACB is $30.00 and the low price target for ACB is $9.00. There are currently 3 sell ratings, 12 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of “Hold.”

Aurora Cannabis has received a consensus rating of Hold. The company’s average rating score is 1.94, and is based on 2 buy ratings, 12 hold ratings, and 3 sell ratings. According to analysts’ consensus price target of $17.13, Aurora Cannabis has a forecasted upside of 171.1% from its current price of $6.32. Aurora Cannabis has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Dividend Strength: Aurora Cannabis (NYSE:ACB)

Aurora Cannabis does not currently pay a dividend. Aurora Cannabis does not have a long track record of dividend growth.

Insiders buying/selling: Aurora Cannabis (NYSE:ACB)

In the past three months, Aurora Cannabis insiders have not sold or bought any company stock. Only 11.49% of the stock of Aurora Cannabis is held by institutions.

Earnings and Valuation of Aurora Cannabis (NYSE:ACB

Earnings for Aurora Cannabis are expected to grow in the coming year, from ($10.56) to ($0.92) per share. The P/E ratio of Aurora Cannabis is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Aurora Cannabis is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Aurora Cannabis has a P/B Ratio of 0.16. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

More latest stories: here